Canopy Growth Corp (CGC) stock price

Canopy Growth Corp (CGC) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $0.94 (-0.15%), Market cap $0.47B, 52-week low–high $0.86 ~ $1.93.

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief,

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Canopy Growth Corp are updated in real time on BlackAll Trade.

Canopy Growth Corp financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Canopy Growth Corp (CGC) stock price?

Canopy Growth Corp trades at $0.94 (-0.15%). Real-time quotes and charts are available on BlackAll Trade.

What is the Canopy Growth Corp (CGC) market cap?

Canopy Growth Corp has a market cap of about $0.47B.

What does Canopy Growth Corp (CGC) do?

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It oper